[ad_1]
Just as many investors and traders remain sanguine about the prospects of cooling U.S. inflation when Thursday’s consumer-price index for June comes out, Wall Street is pointing to the potential inflationary impacts of a second presidency under Republican Donald Trump.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...